The Effect of Smartphone-Based Cognitive Training on the Functional/Cognitive Markers of Schizophrenia: A One-Year Randomized Study

Journal of Clinical Medicine
Marek KrzystanekNapoleon Waszkiewicz

Abstract

Cognitive impairment is associated with long-term disability that results in the deterioration of both the social and professional status of individuals with schizophrenia. The impact of antipsychotic therapy on cognitive function is insufficient. Cognitive training is therefore proposed as a tool for cognitive rehabilitation in schizophrenia. In this study we investigated the effect of self-administered cognitive training using a smartphone-based application on the cognitive function of paranoid schizophrenia patients focusing on response time, correct answer rate, incorrect answer rate, and fatigability to check, if these functions can be functional markers of successful cognitive-smartphone rehabilitation. 1-year multicenter, open-label randomized study was conducted on 290 patients in a state of symptomatic remission. 191 patients were equipped with the full version of the application and conducted cognitive training twice a week. Reference group (n = 99) was provided with a version of the application having only limited functionality, testing the cognitive performance of patients every 6 months. Statistically significant improvement was observed in both the rate of correct answers (by 4.8%, p = 0.0001), and cognitive fatig...Continue Reading

References

Jan 18, 2003·Science·Steven E Hyman, Wayne S Fenton
Jun 23, 2004·Lancet·Kim T Mueser, Susan R McGurk
Mar 3, 2005·The American Journal of Psychiatry·Nancy C AndreasenDaniel R Weinberger
Mar 23, 2005·Biological Psychiatry·Richard S E KeefeMargaret P Poe
Dec 5, 2006·Psychiatry Research·Esther A E HolthausenRobert J van den Bosch
Jun 15, 2007·Schizophrenia Bulletin·Richard S E Keefe, Wayne S Fenton
May 3, 2008·The American Journal of Psychiatry·Somaia MohamedRichard S E Keefe
Jul 25, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rodrigo D PazKuei Y Tseng
Dec 22, 2009·Expert Review of Neurotherapeutics·S Kristian HillJohn A Sweeney
Oct 1, 2010·Clinical Schizophrenia & Related Psychoses·Joshua T Kantrowitz, Daniel C Javitt
Mar 17, 2011·The American Journal of Psychiatry·Til WykesPál Czobor
Sep 19, 2012·Schizophrenia Bulletin·Daniel C Javitt
Feb 23, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Yoshio Kaneko, Matcheri Keshavan
Sep 11, 2013·Psychiatric Rehabilitation Journal·Dror Ben-ZeevDavid C Mohr
Jan 24, 2014·Schizophrenia Research and Treatment·Stefano BarlatiAntonio Vita
May 27, 2014·Archives of Psychiatric Nursing·Jin DangChen Zhang
Feb 27, 2015·Psychiatria polska·Magdalena Linke, Marek Jarema
May 29, 2015·Journal of Mental Health·John A NaslundStephen J Bartels
Nov 8, 2015·JMIR MHealth and UHealth·Joseph Firth, John Torous
Dec 22, 2016·Journal of Medical Internet Research·Patricia A AreanJoaquin A Anguera
Jul 1, 2017·Frontiers in Psychiatry·Laurent Morin, Nicolas Franck
Oct 31, 2017·Journal of Technology in Behavioral Science·Marek KrzystanekKatarzyna Skałacka
Sep 1, 2018·The Journal of Head Trauma Rehabilitation·Eric B ElbogenAysenil Belger
Jul 30, 2020·Journal of Clinical Medicine·Napoleon Waszkiewicz

❮ Previous
Next ❯

Software Mentioned

BrainHQ
STATISTICA
MONEO
Samsung Galaxy

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here